OMERS ADMINISTRATION Corp increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 19.3% during the 1st quarter, Holdings Channel reports. The fund owned 22,835 shares of the company’s stock after acquiring an additional 3,690 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Cardinal Health were worth $4,825,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after acquiring an additional 617,775 shares in the last quarter. State Street Corp grew its position in Cardinal Health by 1.8% during the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after buying an additional 221,497 shares during the period. Geode Capital Management LLC raised its holdings in shares of Cardinal Health by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after purchasing an additional 43,924 shares during the period. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Finally, Norges Bank bought a new position in Cardinal Health during the fourth quarter worth about $790,344,000. Institutional investors own 87.17% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on CAH shares. Citigroup boosted their target price on Cardinal Health from $245.00 to $265.00 and gave the stock a “buy” rating in a research report on Friday. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Morgan Stanley increased their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Evercore cut their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Finally, TD Cowen lifted their target price on shares of Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $251.73.
Cardinal Health Stock Performance
Shares of CAH stock opened at $227.96 on Monday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $243.21. The firm has a market cap of $53.39 billion, a P/E ratio of 34.86, a P/E/G ratio of 1.11 and a beta of 0.49. The business’s 50 day moving average price is $219.98 and its 200-day moving average price is $214.50.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the company earned $2.35 earnings per share. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current year.
Cardinal Health Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.50%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
